questionsmedicales.fr
Personnes
Visiteurs des patients
Visiteurs des patients : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Visiteurs des patients : Questions médicales les plus fréquentes",
"headline": "Visiteurs des patients : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Visiteurs des patients : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-31",
"dateModified": "2025-03-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Visiteurs des patients"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Personnes",
"url": "https://questionsmedicales.fr/mesh/D009272",
"about": {
"@type": "MedicalCondition",
"name": "Personnes",
"code": {
"@type": "MedicalCode",
"code": "D009272",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "M01"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Visiteurs des patients",
"alternateName": "Visitors to Patients",
"code": {
"@type": "MedicalCode",
"code": "D014789",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Samantha J Chiew",
"url": "https://questionsmedicales.fr/author/Samantha%20J%20Chiew",
"affiliation": {
"@type": "Organization",
"name": "Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia."
}
},
{
"@type": "Person",
"name": "Paul H Hemsworth",
"url": "https://questionsmedicales.fr/author/Paul%20H%20Hemsworth",
"affiliation": {
"@type": "Organization",
"name": "Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia."
}
},
{
"@type": "Person",
"name": "Sally L Sherwen",
"url": "https://questionsmedicales.fr/author/Sally%20L%20Sherwen",
"affiliation": {
"@type": "Organization",
"name": "Department of Wildlife Conservation and Science, Zoos Victoria, Parkville, VIC, Australia."
}
},
{
"@type": "Person",
"name": "Grahame J Coleman",
"url": "https://questionsmedicales.fr/author/Grahame%20J%20Coleman",
"affiliation": {
"@type": "Organization",
"name": "Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia."
}
},
{
"@type": "Person",
"name": "Vicky Melfi",
"url": "https://questionsmedicales.fr/author/Vicky%20Melfi",
"affiliation": {
"@type": "Organization",
"name": "Hartpury University and Hartpury College, Gloucester, United Kingdom."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The lncRNA LUCAT1 is elevated in inflammatory disease and restrains inflammation by regulating the splicing and stability of NR4A2.",
"datePublished": "2022-12-28",
"url": "https://questionsmedicales.fr/article/36577072",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1073/pnas.2213715120"
}
},
{
"@type": "ScholarlyArticle",
"name": "The mRNA stability factor Khd4 defines a specific mRNA regulon for membrane trafficking in the pathogen",
"datePublished": "2023-08-17",
"url": "https://questionsmedicales.fr/article/37590419",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1073/pnas.2301731120"
}
},
{
"@type": "ScholarlyArticle",
"name": "Codon Usage and mRNA Stability are Translational Determinants of Cellular Response to Canonical Ferroptosis Inducers.",
"datePublished": "2022-08-17",
"url": "https://questionsmedicales.fr/article/35987429",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.neuroscience.2022.08.009"
}
},
{
"@type": "ScholarlyArticle",
"name": "Genetic polymorphism in untranslated regions of PRKCZ influences mRNA structure, stability and binding sites.",
"datePublished": "2024-09-13",
"url": "https://questionsmedicales.fr/article/39272077",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12885-024-12900-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "IGF2BP3 promotes glutamine metabolism of endometriosis by interacting with UCA1 to enhances the mRNA stability of GLS1.",
"datePublished": "2024-05-17",
"url": "https://questionsmedicales.fr/article/38760723",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s10020-024-00834-7"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Personnes",
"item": "https://questionsmedicales.fr/mesh/D009272"
},
{
"@type": "ListItem",
"position": 3,
"name": "Visiteurs des patients",
"item": "https://questionsmedicales.fr/mesh/D014789"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Visiteurs des patients - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Visiteurs des patients",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Visiteurs des patients",
"description": "Comment évaluer l'impact des visites sur le patient ?\nQuels signes indiquent qu'un patient a besoin de visites ?",
"url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=RNA+Stability&page=7#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Visiteurs des patients",
"description": "Quels symptômes peuvent s'aggraver sans visites ?\nLes visites peuvent-elles réduire la douleur perçue ?",
"url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=RNA+Stability&page=7#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Visiteurs des patients",
"description": "Comment prévenir l'isolement des patients ?\nQuelles mesures prendre pour des visites sûres ?",
"url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=RNA+Stability&page=7#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Visiteurs des patients",
"description": "Les visites font-elles partie du traitement ?\nComment les hôpitaux gèrent-ils les visites ?",
"url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=RNA+Stability&page=7#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Visiteurs des patients",
"description": "Quelles complications peuvent survenir sans visites ?\nLes visites peuvent-elles causer du stress au patient ?",
"url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=RNA+Stability&page=7#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Visiteurs des patients",
"description": "Quels facteurs augmentent le besoin de visites ?\nLes patients en soins intensifs ont-ils plus besoin de visites ?",
"url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=RNA+Stability&page=7#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'impact des visites sur le patient ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'impact peut être évalué par des questionnaires sur le bien-être et l'état émotionnel."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent qu'un patient a besoin de visites ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un patient peut montrer des signes de solitude, d'anxiété ou de dépression."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent s'aggraver sans visites ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'isolement social peut aggraver l'anxiété et la dépression chez le patient."
}
},
{
"@type": "Question",
"name": "Les visites peuvent-elles réduire la douleur perçue ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le soutien émotionnel des visiteurs peut diminuer la perception de la douleur."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'isolement des patients ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Encourager les visites régulières et utiliser des technologies de communication."
}
},
{
"@type": "Question",
"name": "Quelles mesures prendre pour des visites sûres ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Respecter les protocoles d'hygiène et les restrictions de visite en place."
}
},
{
"@type": "Question",
"name": "Les visites font-elles partie du traitement ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les visites peuvent être considérées comme un complément au traitement médical."
}
},
{
"@type": "Question",
"name": "Comment les hôpitaux gèrent-ils les visites ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les hôpitaux établissent des horaires et des règles pour assurer la sécurité des patients."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir sans visites ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'absence de visites peut entraîner une détérioration de la santé mentale et physique."
}
},
{
"@type": "Question",
"name": "Les visites peuvent-elles causer du stress au patient ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des visites non planifiées ou trop fréquentes peuvent causer du stress."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le besoin de visites ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, les maladies chroniques et l'isolement social augmentent ce besoin."
}
},
{
"@type": "Question",
"name": "Les patients en soins intensifs ont-ils plus besoin de visites ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients en soins intensifs peuvent bénéficier davantage du soutien des visiteurs."
}
}
]
}
]
}
The nuclear long non-coding RNA LUCAT1 has previously been identified as a negative feedback regulator of type I interferon and inflammatory cytokine expression in human myeloid cells. Here, we define...
Fungal pathogens depend on sophisticated gene expression programs for successful infection. A crucial component is RNA regulation mediated by RNA-binding proteins (RBPs). However, little is known abou...
Ferroptosis is a non-apoptotic cell death mechanism characterized by the generation of lipid peroxides. While many effectors in the ferroptosis pathway have been mapped, its epitranscriptional regulat...
Variations in untranslated regions (UTR) alter regulatory pathways impacting phenotype, disease onset, and course of disease. Protein kinase C Zeta (PRKCZ), a serine-threonine kinase, is implicated in...
The data related to PRKCZ gene variants was downloaded from the Ensembl genome browser, COSMIC and gnomAD. The RegulomeDB database was used to assess the functional impact of 5' UTR and 3'UTR variants...
The results obtained indicated that a total of 24 variants present in the 3' UTR and 25 variants present in the 5' UTR were most detrimental. TFBS analysis revealed that 5' UTR variants added YY1, rep...
This study laid the groundwork for future studies aimed at targeting PRKCZ as a therapeutic target....
Insulin like growth factor II mRNA binding protein 3 (IGF2BP3) has been implicated in numerous inflammatory and cancerous conditions. However, its precise molecular mechanisms in endometriosis (EMs) r...
Efects of IGF2BP3 on endometriosis were confrmed in vitro and in vivo. Based on bioinformatics analysis, RNA immunoprecipitation (RIP), RNA pull-down assays and Fluorescent in situ hybridization (FISH...
Immunohistochemical staining have revealed that IGF2BP3 was upregulated in ectopic endometriotic lesions (EC) compared to normal endometrial tissues (EN). The proliferation and migration ability of eE...
These discoveries underscored the critical involvement of IGF2BP3 in the elevation and stability of GLS1 mRNA in the context of glutamine metabolism by interacting with UCA1 in EMs. The implications o...
RNase H1 has been acknowledged as an endoribonuclease specializing in the internal degradation of the RNA moiety within RNA-DNA hybrids, and its ribonuclease activity is indispensable in multifaceted ...
The RNA-binding ARS2 protein is centrally involved in both early RNA polymerase II (RNAPII) transcription termination and transcript decay. Despite its essential nature, the mechanisms by which ARS2 e...
Mast cells are central players in allergy and asthma, and their dysregulated responses lead to reduced quality of life and life-threatening conditions such as anaphylaxis. The RNA modification N...
RNA degradosomes are multienzyme complexes composed of ribonucleases, RNA helicases, and metabolic enzymes. RNase E-based degradosomes are widespread in...
Compensation is a defining principle of a true circadian clock, where its approximately 24-hour period length is relatively unchanged across environmental conditions. Known compensation effectors dire...